These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 18164836)
1. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024 [TBL] [Abstract][Full Text] [Related]
3. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379 [TBL] [Abstract][Full Text] [Related]
4. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW; J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058 [TBL] [Abstract][Full Text] [Related]
5. [Long term results of esophageal epidermoid cancers in complete remission after preoperative chemo-radiotherapy]. Triboulet JP; Amrouni H; Guillem P; Vandenhaute B; Lecomte-Houcke M; Adenis A Ann Chir; 1998; 52(6):503-8. PubMed ID: 9752498 [TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease. El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037 [TBL] [Abstract][Full Text] [Related]
7. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651 [TBL] [Abstract][Full Text] [Related]
8. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh G; Vaporciyan A; Lynch PM; Rice DC; Roth JA; Ajani JA Cancer; 2005 Oct; 104(7):1349-55. PubMed ID: 16130133 [TBL] [Abstract][Full Text] [Related]
9. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy. Chao YK; Wu YC; Liu YH; Tseng CK; Chang HK; Hsieh MJ; Chu Y; Liu HP J Surg Oncol; 2010 Aug; 102(2):158-62. PubMed ID: 20648587 [TBL] [Abstract][Full Text] [Related]
10. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892 [TBL] [Abstract][Full Text] [Related]
11. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response. Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531 [TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC; Port JL; Paul S; Stiles BM; Altorki NK Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [TBL] [Abstract][Full Text] [Related]
16. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262 [TBL] [Abstract][Full Text] [Related]
17. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. Berger AC; Farma J; Scott WJ; Freedman G; Weiner L; Cheng JD; Wang H; Goldberg M J Clin Oncol; 2005 Jul; 23(19):4330-7. PubMed ID: 15781882 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499 [TBL] [Abstract][Full Text] [Related]
19. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma]. Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664 [TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]